United States Cost-Effectiveness Study of Two Dry Eye Ophthalmic Lubricants

REFERENCES

• Schaumberg D A, Sullivan D A, Buring J E, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003; 136: 318–326
   PubMed Web of Science ®Google Scholar
• Bandeen-Roche K, Munoz B, Tielsch J M, et al. Self-reported assessment of dry eye in a population-based setting. Invest Ophthalmol Vis Sci 1997; 38: 2469–2475
   PubMed Web of Science ®Google Scholar
• Moss S E, Klein R, Klein B E. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000; 118: 1264–1268
   PubMed Web of Science ®Google Scholar
• Schein O D, Munoz B, Tielsch J M, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997; 124: 723–728
   PubMed Web of Science ®Google Scholar
• Yazdani C, McLaughlin T, Smeeding J E, et al. Prevalence of treated dry eye disease in a managed care population. Clin Ther 2001; 23: 1672–1682
   PubMed Web of Science ®Google Scholar
• Reddy P, Grad O, Rajagopalan K. The economic burden of dry eye: A conceptual framework and preliminary assessment. Cornea 2004; 23: 751–761
   PubMed Web of Science ®Google Scholar
• Dalzell M D. Dry Eye: Prevalence, utilisation, and economic implications. P&T Digest 2003; 12: 9–13
   Google Scholar
• Lemp M A. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J. 1995; 21: 221–232
   PubMedGoogle Scholar
• Chia E M, Mitchell P, Rochtchina E, et al. Prevalence and associations of dry eye syndrome in an older population: The Blue Mountains Eye Study. Clin, ExperOphthalmol 2003; 31: 229–232
   Web of Science ®Google Scholar
• Simmons P A, Vehige J G, Carlisle C, et al. Comparison of dry eye signs in self described mild and moderate patients. Association for Research in Vision, and Ophthalmology Meeting Abstracts 2003; 44(5)2448
   Google Scholar
• Schein O D, Tirlsch J M, Munoz B, et al. Relation between signs and symptoms of dry eye in the elderly—A population based perspective. Ophthalmology 1997; 104: 1395–1401
   PubMed Web of Science ®Google Scholar
• Perry H D, Donnenfeld E D. Medications for dry eye syndrome: A drug-therapy review. P&T Digest 2003; 12: 26–32
   Google Scholar
• Swanson M. Compliance with and typical usage of artificial tears in dry eye conditions. J Am Optom Assoc 1998; 69: 649–655
   PubMedGoogle Scholar
• Balaram M, Schaumberg D A, Dana M R. Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome. Am J Ophthalmol. 2001; 131: 30–36
   PubMed Web of Science ®Google Scholar
• Rajagopalan K, Abetz L, Mertzanis P, et al. Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye. Value Health 2005; 8: 168–174
   PubMed Web of Science ®Google Scholar
• Schiffman R M, Walt J G, Jacobsen G, et al. Utility assessment among patients with dry eye disease. Ophthalmology 2003; 110: 1412–1419
   PubMed Web of Science ®Google Scholar
• Mertzanis P, Abetz L, Rajagopalan K, et al. The relative burden of dry eye in patients' lives: Comparisons to a U.S. normative sample. Invest Ophthalmol, Vis Sci 2005; 46: 46–50
   PubMed Web of Science ®Google Scholar
• Miljanovic B, Dana R, Sullivan D A, et al. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007; 143: 409–415
   PubMed Web of Science ®Google Scholar
• AC Nielsen Point of, Sale Report: First Quarter. 2007
   Google Scholar
• DEWS Report of the International Dry Eye, Workshop (DEWS). Ocular, Surface 2007; 5: 65–199
   Web of Science ®Google Scholar
• Christensen M T, Cohen S, Rinehart J, et al. Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye. Curr Eye Res. 2004; 28: 55–62
   PubMed Web of Science ®Google Scholar
• Sall K N, Cohen S M, Christensen M T, et al. An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye. Eye Contact Lens 2006; 32: 21–26
   PubMedGoogle Scholar
• Noecker R J. Comparison of initial treatment response to two enhanced-viscosity artificial tears. Eye Contact Lens 2006; 32: 148–152
   PubMedGoogle Scholar
• Kunert K S, Tisdale A S, Stern M E, et al. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: Effect on conjunctival lymphocytes. Arch Ophthalmol. 2000; 118: 1489–1496
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188
   PubMed Web of Science ®Google Scholar
• Physicians' Fee and Coding Guide, Vol 2. MAG Mutual Healthcare Solutions Inc., Duluth GA 2007
   Google Scholar
• Nelson J D, Helms H, Fiscella R, et al. A new look at dry eye disease and its treatment. Adv Ther. 2000; 17: 84–93
   PubMed Web of Science ®Google Scholar
• Clegg J P, Guest J F, Lehman A, et al. The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden, and the United Kingdom among patients managed by ophthalmologists. Ophthalmic Epidemiol 2006; 13: 263–274
   PubMed Web of Science ®Google Scholar
• Chiang T H, Walt J G, McMahon J P, Jr., et al. Real-world utilization patterns of cyclosporine ophthalmic emulsion 0.05% within managed care. Can J Clin Pharmacol 2007; 14: e240–5
   Google Scholar
• Brown G C, Brown M M, Sharma S, et al. The burden of age-related macular degeneration: A value-based medicine analysis. Trans Am Ophthalmol Soc. 2005; 103: 173–84, discussion 184–186
   PubMedGoogle Scholar
• Kymes S M, Lee B S. Preference-based quality of life measures in people with visual impairment. Optom Vis Sci. 2007; 84: 809–816
   PubMed Web of Science ®Google Scholar